various/trans-placeholder
Director of Regulatory Affairs

Dr. Annekathrin Haberland, Ph.D.

Dr. Haberland acts as Berlin Cures’ director of regulatory affairs and is also responsible for managing innovation and technology. She introduced aptamer technology to autoantibodies against G-protein coupled receptors after working for an extended period in the laboratory of Priv.-Doz.

Dr. Michael Böttger of the Max Delbrück Center for Molecular Medicine in Berlin-Buch, where she also developed non-viral DNA-vectors and studied protein-DNA-interaction. Dr. Haberland studied pharmacy at the Humboldt University of Berlin and received her Ph.D. in pathomechanisms of the heart and circulatory system with a focus on oxidative stress. She subsequently held several postdoctoral and research scientist positions.

Please use a modern web browser